SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individuals

Area of Science:

• Immunology
• Virology
• Infectious Diseases

Background:

• Understanding T cell responses post-SARS-CoV-2 infection is crucial for developing protective immunity against COVID-19.
• Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection elicits complex immune responses, including T cell activation.

Purpose of the Study:

• To characterize the CD8+ T cell response in individuals recovering from SARS-CoV-2 infection.
• To identify SARS-CoV-2 epitopes recognized by CD8+ T cells and analyze their phenotypic characteristics.
• To model the relationship between T cell responses, time from diagnosis, and humoral/inflammatory markers.

Main Methods:

• Employed a multiplexed peptide-MHC tetramer approach to screen for CD8+ T cell recognition of 408 SARS-CoV-2 epitopes.
• Analyzed T cells from 30 convalescent individuals using a 28-marker phenotypic panel.
• Utilized statistical modeling to correlate T cell responses with clinical and immunological parameters.

Main Results:

• Detected 132 SARS-CoV-2-specific CD8+ T cell responses across 6 HLA types, recognizing 52 unique epitopes.
• Observed SARS-CoV-2-specific CD8+ T cell responses in nearly all convalescent individuals, targeting diverse viral proteins.
• Identified a unique T cell phenotype characterized by early differentiation kinetics, distinct from other virus-specific T cells.

Conclusions:

• SARS-CoV-2-specific CD8+ T cell responses are a common feature of convalescence and exhibit distinct early differentiation patterns.
• The immune response involves coordinated decreases in inflammation and increases in neutralizing antibodies alongside T cell differentiation.
• The differentiation of T cells into stem and transitional memory states suggests a potential mechanism for durable protective immunity against SARS-CoV-2.